About Angelos Stergiou

Angelos Stergiou, MD, ScD h.c. is a driven entrepreneur, scientist and physician who founded SELLAS Life Sciences Group in hopes of giving back to humanity through discovery, clinical research and development.

His focus on biotechnology has opened the doors to the WT1 neoepitope immunotherapeutic multi-peptide treatment agent, which has demonstrated potential to save lives in early trials. Dr. Angelos Stergiou refers to the aforementioned notion as “breathtaking.”

To know more about Dr. Angelos Stergiou read this post http://sellaslifesciences.com/dr-angelos-m-stergiou/